Search Results - "Hoffert, Todd A."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract 2033: Testing the combined effects of low dose olaparib plus ibrutinib on MCL cytotoxicity

    Abstract 2033: Testing the combined effects of low dose olaparib plus ibrutinib on MCL cytotoxicity by Curtis, Adam D., Hoffert, Todd A., Rajan, Sheila S., Rueter, Jens, Shopland, Lindsay S.

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Mantle cell lymphoma (MCL) presents a therapeutic challenge, with frequent relapses after therapy due to high levels of DNA damage and disease evolution. One…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Abstract 36: Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates (ADCs) demonstrate tumor specificity in vitro and in vivo antitumor efficacy

    Abstract 36: Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates (ADCs) demonstrate tumor specificity in vitro and in vivo antitumor efficacy by Prendergast, Jillian M., Eavarone, David A., Rao, Patricia E., Curtis, Adam D., Shopland, Lindsay S., Hoffert, Todd A., Stein, Jenna, Behrens, Jeff, Dransfield, Daniel T.

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Tumor-associated carbohydrate antigens (TACAs) historically have been challenging targets for antibody therapeutics. Sialyl-Tn (STn) is a cancer specific…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: